Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
The aim is to separate promising ideas from treatments that have been properly tested in humans, especially when Crohns disease or ulcerative colitis may be active
Surveys from PAS and clinical experience teach us that there is a subgroup of individuals (almost 50%) who need more frequent injections to remain symptom-free
A significant proportion of the published work comes from a single research group the Zagreb laboratory associated with Sikiric and colleagues
Treatment is often initiated at a high dose, followed by a maintenance dose given less frequently, as determined by the patient's B12 levels and clinical response
CPD UK is globally recognised by employers, professional organisations, and academic institutions
US$ 26.28
US$ 21.48
US$ 27.77
